Your browser doesn't support javascript.
loading
Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of DICER1 syndrome.
Golmard, Lisa; Vasta, Lauren M; Duflos, Valérie; Corsini, Carole; Dubois d'Enghien, Catherine; McMaster, Mary L; Harney, Laura A; Carr, Ann G; Ling, Alexander; Dijoud, Frédérique; Gauthier, Arnaud; Miettinen, Markku; Cost, Nicholas G; Gauthier-Villars, Marion; Orbach, Daniel; Irtan, Sabine; Haouy, Stéphanie; Schultz, Kris Ann; Stoppa-Lyonnet, Dominique; Coupier, Isabelle; Stewart, Douglas R; Sirvent, Nicolas.
Affiliation
  • Golmard L; Department of Genetics, PSL Research University, Institut Curie, Paris, France lisa.golmard@curie.fr.
  • Vasta LM; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • Duflos V; National Capital Consortium, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
  • Corsini C; Department of Pediatric Oncology, University Hospital Centre Montpellier, Montpellier, France.
  • Dubois d'Enghien C; Department of Genetics, University Hospital Centre Montpellier, Montpellier, France.
  • McMaster ML; Department of Genetics, PSL Research University, Institut Curie, Paris, France.
  • Harney LA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • Carr AG; Westat, Rockville, Maryland, USA.
  • Ling A; Westat, Rockville, Maryland, USA.
  • Dijoud F; NIH Clinical Center, Bethesda, Maryland, USA.
  • Gauthier A; Department of Pathology, Centre de Pathologie Est, Hospices Civils de Lyon, Bron, France.
  • Miettinen M; Department of Pathology, PSL Research University, Institut Curie, Paris, Île-de-France, France.
  • Cost NG; Laboratory of Pathology, Center for Cancer Research, Bethesda, Maryland, USA.
  • Gauthier-Villars M; Department of Surgery, Division of Urology, Pediatric Urology and Urologic Oncology, Department of Pediatrics, Section of Hematology and Oncology, Pediatric Oncology, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Orbach D; Department of Genetics, PSL Research University, Institut Curie, Paris, France.
  • Irtan S; SIREDO Oncology Center, PSL Research University, Institut Curie, Paris, Île-de-France, France.
  • Haouy S; Trousseau Hospital, Department of Pediatric Surgery, AP-HP, Paris, Île-de-France, France.
  • Schultz KA; Department of Pediatric Oncology, University Hospital Centre Montpellier, Montpellier, France.
  • Stoppa-Lyonnet D; Cancer and Blood Disorders, Children's Minnesota, Minneapolis, Minnesota, USA.
  • Coupier I; Department of Genetics, INSERM U830, Institut Curie, Paris, Île-de-France, France.
  • Stewart DR; Paris University, Paris, Île-de-France, France.
  • Sirvent N; Department of Genetics, University Hospital Centre Montpellier, Montpellier, France.
J Med Genet ; 59(4): 346-350, 2022 04.
Article in En | MEDLINE | ID: mdl-33782093
ABSTRACT
DICER1 syndrome is a rare paediatric autosomal dominant inherited disorder predisposing to various benign and malignant tumours. It is caused by a germline pathogenic variant in DICER1, and the second hit for tumour development is usually a missense hotspot pathogenic variant in the DICER1 ribonuclease IIIb domain. While DICER1 predisposing variants account for about 60% of ovarian Sertoli-Leydig cell tumours, no DICER1-related testicular stromal tumours have been described. Here we report the first two cases of testicular stromal tumours in children carrying a DICER1 germline pathogenic variant a case of Sertoli cell tumour and a case of Leydig cell tumour diagnosed at 2 and 12 years of age, respectively. A somatic DICER1 hotspot pathogenic variant was detected in the Sertoli cell tumour. This report extends the spectrum of DICER1-related tumours to include testicular Sertoli cell tumour and potentially testicular Leydig cell tumour. Diagnosis of a testicular Sertoli cell tumour should prompt DICER1 genetic testing so that patients with a DICER1 germline pathogenic variant can benefit from established surveillance guidelines. DICER1 genetic evaluation may be considered for testicular Leydig cell tumour. Our findings suggest that miRNA dysregulation underlies the aetiology of some testicular stromal tumours.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Sertoli Cell Tumor / Testicular Neoplasms / Neoplastic Syndromes, Hereditary / Sertoli-Leydig Cell Tumor / Leydig Cell Tumor Type of study: Diagnostic_studies / Guideline Limits: Child / Female / Humans / Male Language: En Journal: J Med Genet Year: 2022 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Sertoli Cell Tumor / Testicular Neoplasms / Neoplastic Syndromes, Hereditary / Sertoli-Leydig Cell Tumor / Leydig Cell Tumor Type of study: Diagnostic_studies / Guideline Limits: Child / Female / Humans / Male Language: En Journal: J Med Genet Year: 2022 Document type: Article Affiliation country: Francia